|
|
|
|
|
|
PharmWeb GMP Forum
01 January, 2009 | |||
| 18:38 | Re: Cleaning | Malcolm Ross" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
06 January, 2009 | |||
| 13:53 | identity testing(annex 8) | Safwa Al-MOUSA" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:55 | F0 value suggestion | rcpantola" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:56 | vial washer validation | Tzafrir" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:57 | conversion factor | RESEARCH" (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
07 January, 2009 | |||
| 20:38 | Re: F0 value suggestion | Global ConSeptS" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:39 | Re: vial washer validation | JOHN WHITE (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:40 | RE: vial washer validation | Nimrod Leuw" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:42 | Re: conversion factor | Kaustubh Tambwekar (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:44 | Re: conversion factor | Malcolm Ross" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:44 | Re: Cleaning | JOHN WHITE (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:45 | Re: F0 value suggestion | Jean-Denis Mallet" (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
| 20:48 | Re: identity testing(annex 8) | Jean-Denis Mallet" (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
08 January, 2009 | |||
| 13:24 | Complaint Closure Timeframes | Anthony McMahon" (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
| 13:26 | Facial Hair | Siswanto" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:27 | F0 value suggestion | Brian MATTHEWS" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:29 | Re: F0 value suggestion | Jim Tyrrell (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 17:53 | RE: Complaint Closure Timeframes | Kathleen Fritts" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 17:53 | Re: Facial Hair | Malcolm Ross" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 17:55 | Re: vial washer validation | rajus02@yahoo.co.in (by way of John Dolman) | |
| 17:56 | API Retesting (vs Shelf Life) | Steve Stuart" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 17:56 | Re: Facial Hair | Jean-Denis Mallet" (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
| 17:57 | Re: F0 value suggestion | rajus02@yahoo.co.in (by way of John Dolman) | |
| 18:16 | Re: F0 value suggestion | Brian MATTHEWS" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 21:54 | Re: API Retesting (vs Shelf Life) | Malcolm Ross" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
09 January, 2009 | |||
| 13:42 | Re: F0 value suggestion | Global ConSeptS" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:45 | RE: F0 value suggestion | Meriam Lindsay" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:46 | RE: API Retesting (vs Shelf Life) | Bob Kirsch" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
11 January, 2009 | |||
| 11:25 | Re: Complaint Closure Timeframes | Malcolm Ross" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 11:59 | number of thermocouples and BI in tunnel validation | tzafrir" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
12 January, 2009 | |||
| 13:15 | RE: Facial Hair | mkzaman ." (by way of John Dolman<info@the-dolman-consultancy.com>) | |
13 January, 2009 | |||
| 11:49 | Production Line for peptide API | lingahu" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
08 February, 2009 | |||
| 13:59 | What's FDA's attitude to Ozone sanitization in HVAC | Forest" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 14:01 | Campaign of mixing process | Martha Sitompul" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 14:03 | Hand wash facilties in Grade C to B changeroom | Maureen Dennehy" (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
| 15:06 | clinical trials | Del V (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 21:53 | RE: Hand wash facilties in Grade C to B changeroom | Terry Snape" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 21:56 | RE: What's FDA's attitude to Ozone sanitization in HVAC | Stephen Brown" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
09 February, 2009 | |||
| 18:43 | Re: What's FDA's attitude to Ozone sanitization in HVAC | Amer Almalakh (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:46 | RE: clinical trials | Qureshi, Sabiha" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:47 | RE: clinical trials | Office Manager" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 19:47 | Re: What's FDA's attitude to Ozone sanitization in HVAC | alex.kennedy@validation-online.net (by way of John Dolman) | |
10 February, 2009 | |||
| 18:26 | Revalidation Frequency of Lyophlizer by Media Fill | "C. Schröter" (byway of John Dolman <info@the-dolman-consultancy.com>) | |
| 18:27 | RE: GMP Discussion Group Digest - 10/02/09 | Teria Viljoen" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:31 | RE: What's FDA's attitude to Ozone sanitization in HVAC | Stephen Brown" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:32 | Software Validation | sainath gadam" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:34 | RE: What's FDA's attitude to Ozone sanitization in HVAC | Stephen Brown" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:35 | RE: clinical trials | rajamaniiyer@shasun.com (by way of John Dolman) | |
| 19:31 | Can we change the Generic product pH? | kasis@drreddys.com (by way of John Dolman) | |
12 February, 2009 | |||
| 10:28 | Re: Software Validation | Deirdre Matthews (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 10:29 | Re: clinical trials | Efrem Zaret (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 10:30 | swabs by TOC | (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 10:33 | Re: Revalidation Frequency of Lyophlizer by Media Fill | rajamaniiyer@shasun.com (by way of John Dolman) | |
| 10:34 | Re: What's FDA's attitude to Ozone sanitization in HVAC | alex.kennedy@validation-online.net (by way of John Dolman) | |
| 11:30 | CB 30 | rajamaniiyer@shasun.com (by way of John Dolman) | |
| 11:35 | RE: Software Validation | Orlando Lopez (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 11:37 | Re: Revalidation Frequency of Lyophlizer by Media Fill | Jean-Denis Mallet (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 12:37 | Re: What's FDA's attitude to Ozone sanitization in HVAC | Amer Almalakh (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:50 | Re: Revalidation Frequency of Lyophlizer by Media Fill | Ravi Menon (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 19:49 | Re: What's FDA's attitude to Ozone sanitization in HVAC | Ravi Menon (by way of John Dolman<info@the-dolman-consultancy.com>) | |
13 February, 2009 | |||
| 14:50 | RE: CB 30 | Bob Kirsch" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
14 February, 2009 | |||
| 20:21 | Hardness testing of Tablets | Ashok Bhatnagar" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
15 February, 2009 | |||
| 13:14 | validation reg. | srinivasan m (by way of John Dolman<info@the-dolman-consultancy.com>) | |
16 February, 2009 | |||
| 21:29 | Re: Software Validation | Del V (by way of John Dolman<info@the-dolman-consultancy.com>) | |
17 February, 2009 | |||
| 14:36 | Cleaning validation | Nimesh Solanki" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 16:42 | Objectionable organisms | Brian MATTHEWS" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
19 February, 2009 | |||
| 13:20 | RE: Objectionable organisms | Office Manager" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:22 | Re: Campaign of mixing process | Malcolm Ross (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:25 | Indian Requirements for Importation of Drug Product | Office Manager" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 14:25 | visible particles in injectables | Paula Fernández (by way ofJohn Dolman <info@the-dolman-consultancy.com>) | |
| 15:24 | Re: Cleaning validation | rajamaniiyer@shasun.com (by way of John Dolman) | |
| 15:25 | Isolator for Biohazardous Material | Frank Talbot" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
20 February, 2009 | |||
| 13:05 | RE: visible particles in injectables | Frank Bales (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 13:05 | Compressed air - process air | angela.white@ipsen.com (by way of John Dolman) | |
| 18:20 | Reporting of Engineering to Production | Steve Stuart" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 19:19 | RE: visible particles in injectables | Newbery, Alan" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
21 February, 2009 | |||
| 19:14 | Re: validation reg. | Del V (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 19:14 | Re: Cleaning validation | Del V (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 19:15 | Re: Isolator for Biohazardous Material | Del V (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 19:18 | Re: Reporting of Engineering to Production | JOHN WHITE (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:11 | Re: Reporting of Engineering to Production | Amer Almalakh (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:13 | Re: visible particles in injectables | Jatin Shah" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 20:15 | RE: Reporting of Engineering to Production | Newbery, Alan" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 21:14 | Reporting results lower than the LOD | Miguel Castellanos (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
| 21:14 | dirty equipment hold tome study. | GOWHAR RAJA VANDANAPU (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
| 21:16 | Re: visible particles in injectables | alex.kennedy@validation-online.net (by way of John Dolman) | |
23 February, 2009 | |||
| 17:42 | Re: dirty equipment hold tome study. | rajamaniiyer@shasun.com (by way of John Dolman) | |
| 17:43 | RE: Reporting results lower than the LOD | Bob Kirsch" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 17:46 | Re: validation reg. | srinivasan m (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 17:46 | Re: Reporting results lower than the LOD | manohar@shasun.com (by way of John Dolman) | |
| 17:48 | Re: Reporting results lower than the LOD | Jatin Shah" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 18:52 | RE: visible particles in injectables | Global ConSeptS EURL" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
| 19:48 | Re: Isolator for Biohazardous Material | Chris Barnett" (by way of JohnDolman <info@the-dolman-consultancy.com>) | |
24 February, 2009 | |||
| 19:41 | Re: Isolator for Biohazardous Material | alex.kennedy@validation-online.net (by way of John Dolman) | |
01 March, 2009 | |||
| 10:54 | Compressed air - process air requirement to test for other gases | Ravi Menon (by way of John Dolman<info@the-dolman-consultancy.com>) | |
03 March, 2009 | |||
| 13:25 | Vacuum Leak Testing for Nasal Sprays | Myrelle Antonio" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
06 March, 2009 | |||
| 16:48 | Filter integrity check | Del V (by way of John Dolman<info@the-dolman-consultancy.com>) | |
07 March, 2009 | |||
| 13:21 | Re: Filter integrity check | rajamaniiyer@shasun.com (by way of John Dolman) | |
| 14:20 | Manufacturing of mutagenic API | Vamsi" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
08 March, 2009 | |||
| 23:00 | Newcomer questions | Christian" (by way of John Dolman<info@the-dolman-consultancy.com>) | |
|
|
|
MHonArc 2.3.3